111
Views
0
CrossRef citations to date
0
Altmetric
Articles

Age and sex or gender (sex/gender) and HIV vaccine preparedness

Pages 505-524 | Received 26 Apr 2015, Accepted 08 Sep 2015, Published online: 29 Oct 2015

References

  • Andrasik, M. P., Yoon, R., Mooney, J., Broder, G., Bolton, M., Votto, T., … Eckstein, D. (2014). Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials. Prevention Science, 15, 268–276.10.1007/s11121-013-0371-0
  • Bekker, L.-G., Jaspan, H., McIntyre, J., Wood, R., & Gray, G. (2005). Adolescents and HIV vaccine trials: What are the clinical trial site issues? Journal of the International Association of Physicians in AIDS Care, 4, 93–97.10.1177/1545109705284836
  • Brown-Peterside, P., Chiasson, M. A., Ren, L., & Koblin, B. A. (2000). Involving women in HIV vaccine efficacy trials: lessons learned from a vaccinepreparedness study in New York City. Journal of Urban Health, 77, 425–437.
  • Brown-Peterside, P., Rivera, E., Lucy, D., Slaughter, I., Ren, L., Chiasson, M.A., … Koblin BA. (2001). Retaining hard-to-reach women in HIV preventionand vaccine trials: Project ACHIEVE. American Journal of Public Health, 91, 1377–1379.
  • Buchbinder, S. P., Douglas, Jr. J. M., McKirnan, D. J., Judson, F. N., Katz, M. H., & MacQueen, K. M. (1996). Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate. Journal of Infectious Diseases, 174, 954–961.10.1093/infdis/174.5.954
  • Carneiro, M., de Figueiredo Antunes, C. M., Greco, M., Oliveira, E., Andrade, J., & Lignani, Jr. L. (2000). Design, implementation, and evaluation at entry of a prospective cohort study of homosexual and bisexual HIV-1-negative men in Belo Horizonte, Brazil: Project Horizonte. Journal of Acquired Immune Deficiency Syndromes, 25, 182–187.
  • Celentano, D. D., Beyrer, C., Natpratan, C., Eiumtrakul, S., Sussman, L., Renzullo, P. O., … Nelson, K. E. (1995). Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS, 9, 1079–1083.10.1097/00002030-199509000-00015
  • Chu, Z., Xu, J., Reilly, K. H., Lu, C., Hu, Q., Ma, N., … Shang, H. (2013). HIV related high risk behaviors and willingness to participate in HIV vaccine trials among China MSM by computer assisted self-interviewing survey. BioMed Research International, Article ID 493128.
  • de Bruyn, G., Skhosana, N., Robertson, G., McIntyre, J. A., & Gray, G. E. (2008). Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Research Notes, 1, 76.10.1186/1756-0500-1-76
  • Deschamps, M. M., Johnson, Jr. W. D., & Pape, J. P. (1994). Feasibility and cohort development for HIV vaccine trials in Haiti. AIDS Research and Human Retroviruses, 10(Suppl.2), S231–S233.
  • Deschamps, M. M., Zorrilla, C. D., Morgan, C. A., Donastorg, Y., Metch, B., Madenwald, T., … Pape, J. W. (2013). Recruitment of Caribbean female commercial sex workers at high risk of HIV infection. Revista Panamericana de Salud Pública, 34, 92–98.
  • Dhalla, S., Poole, G., Singer, J., Patrick, D. M., Wood, E., & Kerr, T. (2010). Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users. Vaccine, 28, 1663–1667.10.1016/j.vaccine.2009.12.023
  • Djomand, G., Metch, B., Zorrilla, C. D., Donastorg, Y., Casapia, M., Villafana, T., … Pape, J. (2008). The HVTN protocol 903 vaccine preparedness study: Lessons learned in preparation for HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 48, 82–89.10.1097/QAI.0b013e31817236ab
  • Etcheverry, M. F., Evans, J. L., Sanchez, E., Mendez-Arancibia, E., Meroño, M., Gatell, J. M., … Joseph J. (2013). Enhanced retention strategies andwillingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials. Human Vaccines &Immunotherapeutics, 9, 420–429.
  • Etcheverry, M. F., de Lazzari, E., Fuchs, J. D., Merono, M., Sierra, E., Del Romero, J., … Joseph, J. (2010). Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain. AIDS and Behavior, 14, 607–617.10.1007/s10461-008-9486-x
  • Etcheverry, M. F., Lum, P. J., Evans, J. L., Sanchez, E., de Lazzari, E., Mendez-Arancibia, E., … Joseph J. (2011). HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. Vaccine, 29, 1991–1996.
  • Francis, D. P., Heyward, W. L., Popovic, V., Orozco-Cronin, P., Orelind, K., Gee, C., … Berman, P. W. (2003). Candidate HIV/AIDS vaccines: Lessons learned from the world’s phase 3 efficacy trials. AIDS, 17, 147–156.10.1097/00002030-200301240-00003
  • Fuchs, J., Durham, M., McLellan-Lemal, E., Vittinghoff, E., Colfax, G., Gurwith, M., … Buchbinder, S. (2007). Negative social impacts among volunteers in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes, 46, 362–368.10.1097/QAI.0b013e3181565dcb
  • Geis, S., Maboko, L., Saathoff, E., Hoffmann, O., Geldmacher, C., Mmbando, D., … Hoelscher M. (2011). Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya region, Tanzania. Journal of Acquired Immune Deficiency Syndromes, 56, 453–459.10.1097/QAI.0b013e3182118fa3
  • Golub, E. T., Purvis, L.A., Sapun, M., Safaeian, M., Beyrer, C., Vlahov, D.,… Strathdee, S.A.(2005). Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS and Behavior, 9, 301–309.
  • Gray, G. E., Moodie, Z., Metch, B., Gilbert, P. B., Bekker, L. G., Churchyard, G., … HVTN 503/Phambili study team. (2014). Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: Unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. Lancet Infectious Diseases, 14, 388–396.10.1016/S1473-3099(14)70020-9
  • Gross, M., Seage, G. R., Mayer, K. A., Goldstein, R. S., Losina, E., & Wold, C. (1996). Interest among gay/bisexual men in greater Boston in participating in clinical trials of preventive HIV vaccines. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 406–412.10.1097/00042560-199608010-00012
  • Hays, R. B., & Kegeles, S. M. (1999). Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 164–171.10.1097/00042560-199902010-00009
  • Jackson, D. J., Martin, Jr. H. L., Bwayo, J. J., Nyange, P. M., Rakwar, J. P., Kashonga, F., … Kreiss, J. K. (1995). Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya. AIDS, 9, 1279–1283.10.1097/00002030-199511000-00010
  • Jaspan, H. B., Berwick, J. R., Myer, L., Mathews, C., Flisher, A. J., Wood, R., … Bekker, L.-G. (2006). Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. Journal of Adolescent Health, 39, 642–648.10.1016/j.jadohealth.2006.05.016
  • Jenkins, R. A., Torugsa, K., Markowitz, L. E., Mason, C. J., Jamroentana, V., Brown, A. E., … Nitayaphan, S. (2000). Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections, 76, 386–392.10.1136/sti.76.5.386
  • Johnson, A. S., Hall, H. I., Hu, X., Lansky, A., Holtgrave, D. R., & Mermin, J. (2014). Trends in diagnoses of HIV infection in the United States. Journal of the American Medical Association, 312, 432–434.10.1001/jama.2014.8534
  • Kempf, M. C., Allen, S., Zulu, I., Kancheya, N., Stephenson, R., Brill, I., … Rwanda Zambia HIV Research Group. (2008). Enrollment and retention of HIV discordant couples in Lusaka, Zambia. Journal of Acquired Immune Deficiency Syndromes, 47, 116–125.10.1097/QAI.0b013e31815d2f3f
  • Kiwanuka, N., Robb, M., Kigozi, G., Birx, D., Philips, J., Wabwire-Mangen, F., … Gray, R. H. (2004). Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: A population-based study, Rakai, Uganda. Journal of Acquired Immune Deficiency Syndromes, 36, 721–725.10.1097/00126334-200406010-00009
  • Kiwanuka, N., Ssetaala, A., Mpendo, J., Wambuzi, M., Nanvubya, A., Sigirenda, S., … Sewankambo, N. K. (2013). High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. Journal of the International AIDS Society, 16, 1–7.
  • Koblin, B. A., Avrett, S., Taylor, P. E., & Stevens, C. E. (1997). Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 165–171.10.1097/00042560-199706010-00011
  • Koblin, B. A., Heagerty, P., Sheon, A., Buchbinder, S., Celum, C., Douglas, J. M., … Seage G. (1998). Readiness of high-risk populations in the HIV network for prevention trials to participate in HIV vaccine efficacy trials in the United States. AIDS, 12, 785–793.10.1097/00002030-199807000-00015
  • Koblin, B. A., Holte, S., Lenderking, B., & Heagerty, P. (2000). Readiness for HIV vaccine trials: changes in willingness and knowledge among highriskpopulations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. Journal of Acquired ImmuneDeficiency Syndromes, 24, 451–457.
  • Koblin, B. A., Mayer, K. H., Eshleman, S. H., Wang, L., Mannheimer, S., del Rio, C., … HPTN 061 Protocol Team. (2013). Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV Prevention Trials Network (HPTN) 061. PLoS ONE, 8, e70413.
  • Koblin, B. A., Taylor, P. E., Avrett, S., & Stevens, C. E. (1996). The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York City: Project ACHIEVE. AIDS, 10, 1555–1561.10.1097/00002030-199611000-00015
  • Li, Q., Luo, F., Zhou, Z., Li, S., Liu, Y., Li, D., … Shao, Y. (2010). Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men. Vaccine, 28, 4638–4643.10.1016/j.vaccine.2010.04.073
  • Ma, M., Toni Young, A., Durham, M., Kibler, J. L., Gaul, Z., Pals, S., … Sutton, M. Y. (2014). Predictors of willingness of participate in HIV vaccine trials among African Americans. Journal of AIDS & Clinical Research, 5, 361.
  • Markowitz, L. E., Sirisopana, N., Charonwatanachokchai, A., Julvanichpong, W., Siraprapasiri, T., Palanuvej, T., … Brown, A. E. (1999). Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 488–494.10.1097/00042560-199904150-00012
  • Marmor, M., Titus, S., Wolfe, H., Krasinski, K., Maslansky, R., Simberkoff, M., … Des Jarlais DC. (1994). Retention, behavior change and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. AIDS Research and Human Retroviruses, 110, S207–S213.
  • McGrath, J. W., George, K., Svilar, G., Ihler, E., Mafigiri, D., & Kabugo, M. (2001). Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndromes, 27, 381–388.10.1097/00126334-200108010-00009
  • Metch, B., Frank, I., Novak, R., Swann, E., Metzger, D., Morgan, C., … Koblin B.(2013). Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials. AIDS and Behavior, 17, 760–772.
  • Meque, I., Dubé, K., Bierhuizen, L., Zango, A., Veldhuijzen, N., Cumbe, F., & van de Wijgert, J. (2014). Willingness to participate in future HIV prevention trials in Beira, Mozambique. African Journal of AIDS Research, 13, 393–398.10.2989/16085906.2014.985239
  • Meyers, K., David, S., Metzger, D. S., Navaline, H., Woody, G. E., & McLellan, T. (1994). HIV vaccine trials: Will intravenous drug users enroll? American Journal of Public Health, 84, 761–766.10.2105/AJPH.84.5.761
  • Middelkoop, K., Myer, L., Mark, D., Mthimunye, D. P., Smit, J., Wood, R., … Bekker, L.-G. (2008). Journal of Adolescent Health, 43, 8–14.10.1016/j.jadohealth.2007.11.144
  • Mills, E. J., Nixon, S., Singh, S., Dolma, S., Nayyar, A., & Kapoor, S. (2006). Enrolling women into HIV preventive vaccine trials: An ethical imperative but a logistical challenge. PLoS Medicine, 3, e94.
  • Natpratan, C., Nantakwang, D., Beyrer, C., Kunawararak, P., Gunhom, C., Celentano, D. D., … Khamboonruang, C. (1996). Feasibility of northern Thai factory workers as participants in HIV vaccine trials. Southeast Asian Journal of Tropical Medicine and Public Health, 27, 457–462.
  • Newman, P. A., Chakrapani, V., Weaver, J., Shunmugam, M., & Rubincam, C. (2014). Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India. Vaccine, 32, 5854–5861.10.1016/j.vaccine.2014.08.043
  • Olanrewaju, O., Onigbogi, M. O., & Omobola, O. (2014). Willingness to participate (WTP) in HIV vaccine trials among itinerant female hairdressers in Ibadan, Nigeria. Journal of AIDS and Clinical Research, 5, 325.
  • Otwombe, K. N., Sikkema, K. J., Dietrich, J., de Bruyn, G., van derWatt, M., & Gray, G. E. (2011). Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: A survey conducted among adolescents in Soweto, South Africa. Journal of Acquired Immune Deficiency Syndromes, 58, 211–218.10.1097/QAI.0b013e31822b7702
  • Périssé, A.R., Schechter, M., Moreira, R. I., do Lago, R. F., Santoro-Lopes, G., & Harrison, L. H. (2000). Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes, 25, 459–463.10.1097/00126334-200012150-00012
  • Pitisuttithum, P., Choopanya, K., Bussaratid, V., Vanichseni, S., Van Griensven, F., Phonrat, B., … Francis, D. (2007). Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand. Journal of the Medical Association of Thailand, 90, 2442–2448.
  • Price, M. A., Rida, W., Mwangome, M., Middelkoop, K., Roux, S., Okuku, H. S., & Sanders, E. J. (2012). Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report xex with men, sex workers, and youth. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 59, 185–193.10.1097/QAI.0b013e31823d8693
  • Ruzagira, E., Wandiembe, S., Bufumbo, L., Levin, J., Price, M. A., Grosskurth, H., … Kamali, A. (2009). Willingness to participate in preventive HIV vaccine trials in a community based cohort in south western Uganda. Tropical Medicine & International Health, 14, 196–203.
  • Sahay, S., Mehendale, S., Sane, S., Brahme, R., Brown, A., Charron, K., … Paranjape, R. (2005). Correlates of HIV vaccine trial participation: An Indian perspective. Vaccine, 23, 1351–1358.10.1016/j.vaccine.2004.09.032
  • Scheer, S., Douglas, J. M., Vittinghoff, E., Bartholow, B. N., McKirnan, D., Judson, F. N., … Buchbinder, S. (1999). Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 172–178.10.1097/00042560-199902010-00010
  • Seage, G. R. 3rd, Holte, S. E., Metzger, D., Koblin, B. A., Gross, M., Celum, C., … Buchbinder, S. P. (2001). Are US populations appropriate for trials ofhuman immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. American Journal of Epidemiology, 153, 619–627.
  • Starace, F., Wagner, T. M., Luzi, A. M., Cafaro, L., Gallo, P., & Rezza, G. (2006). Knowledge and attitudes regarding preventive HIV vaccine clinical trials in Italy: Results of a national survey. AIDS Care, 18, 66–72.10.1080/09540120500161777
  • Strathdee, S. A., Hogg, R. S., Cornelisse, P. G., Martindale, S. L., Currie, S. L., O’Shaugnessy, M. V., … Schechter, M. T. (2000). Factors associated with willingness to participate in HIV vaccine trials among HIV-negative injection drug users and young gay and bisexual men. AIDS and Behavior, 4, 271–278.10.1023/A:1009520802874
  • Suhadev, M., Nyamathi, A. M., Swaminathan, S., Suresh, A., & Venkatesan, P. (2009). Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Research and Human Retroviruses, 25, 217–224.10.1089/aid.2007.0312
  • Tello, J., Soong, S., Hunter, B., Meriwether, R., HOOK, E.W., & Mulligan, M. J. (1998). HIV vaccine acceptance among heterosexual clients of a sexually transmitted diseases clinic. American Journal of the Medical Sciences, 315, 11–16.10.1097/00000441-199801000-00003
  • Van de Ven, P., Mao, L., Crawford, J., Prestage, G., Grulich, A., Kaldor, J., … Kippax S. (2005). Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia. International Journal of STD and AIDS, 16, 314–317.10.1258/0956462053654212
  • Volk, J. E., Hessol, N. A., Gray, G. E., Kublin, J. G., Churchyard, G. J., Mlisana, K., … Bekker, L.-G. (2014). The HVTN503/Phambili HIV vaccine trial: A comparison of younger and older participants. International Journal of STD and AIDS, 25, 332–340.10.1177/0956462413506892
  • Woody, G.E., Metzger, D., & Mulvaney, F. Preparations for AIDS vaccine trials. (1994). Recruitment and retention of in- and out-of-treatment injection drug users. AIDS Research and Human Retroviruses, 10( Suppl 2), S197–199.
  • Yin, L., Zhang, Y., Qian, H. Z., Rui, B., Zhang, L., Zhu, J., … Shao Y. (2008). Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine, 26, 762–768.10.1016/j.vaccine.2007.11.091

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.